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1. Introduction 
Age-related macular degeneration (AMD) involves progressive cell death of post-mitotic 
retinal pigment epithelial (RPE) cells, which adversely affects rod and cone survival. RPE 
cells are exposed to chronic oxidative stress, including constant exposure to intense light 
and increased reactive oxygen species (ROS) from mitochondria due to high levels of 
oxygen consumption. However, understanding how oxidative stress causes 
phosphoproteomic alterations that initiate death signals in the RPE is elusive. Lack of such 
knowledge is an important problem, because, without it, acquiring the ability to modulate 
cellular protection is highly unlikely.  
The RPE, located between photoreceptors and choroid, is in a unique position to mediate the 
transport of nutrients, oxygen, and retinoid from blood to photoreceptors. For continued 
vision, the RPE is required for retinoid recycling and phagocytosis, which initiates 
accumulation of retinoid byproducts that eventually leads to apoptosis. Continuous 
exposure to light causes the RPE to consume a large amount of oxygen in order to complete 
the complex processes of nutrient transport, phagocytosis, and the visual cycle. It is still not 
known why the initial retinal degeneration occurs and how the degenerative processes 
progress as a result of oxidative stress. Adaptation to changes in oxidative environment is 
critical for the survival of retina and RPE cells. Clinical trials demonstrated a significant 
reduction toward retinal degeneration upon intake of antioxidants that include lutein, 
zeaxanthin, zinc, vitamin C, and vitamin E. Oxidation of polyunsaturated fatty acids (PFA) 
and photosensitizers in the RPE induces reactive oxygen species (ROS) production upon 
exposure to visible light. Hydrogen peroxide (H2O2) is generated in the RPE during 
phagocytosis of the photoreceptor outer segment, and it has been used as a direct oxidative-
inducing reagent to initiate cellular oxidative stress. Understanding of molecular 
mechanisms that mediate oxidative stress-induced proteome changes in the RPE may 
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provide insight into the pathogenesis of retinal degeneration. In our study, comparative and 
differential proteomics have been applied to investigate global changes in the RPE and 
retina proteome due to oxidative stress induced by light or H2O2.  
2. Phosphorylation signaling in the RPE  
We have focused on understanding the cell death mechanism of the retina and RPE under 
oxidative stress [Chung et al., 2009; Lee et al., 2010a; Lee et al., 2010b; Zhang et al., 2010; Lee 
et al., 2011; Arnouk et al., 2011; Sripathi et al., 2011]. Our studies demonstrated that 
oxidative stress may trigger induction of anti-apoptotic erythropoietin, JAK2, and BCL-xL, 
as well as pro-apoptotic caspases. Oxidative stress also influences mitochondrial-nuclear 
communication by shuttling mitochondrial prohibitin. We examined whether 
phosphorylations of cytoskeletal and anti-apoptotic proteins, including vimentin, PP2A, and 
crystalline, regulate the initial protecting mechanism. The cytoskeletal network formed by 
filamentous proteins determines how retinal and RPE cells respond to their extracellular 
environmental stimuli that include oxidative stress.  
Site-specific phosphorylations of crystalline and vimentin regulate protein interactions 
through positive or negative feedback mechanisms. The significance of proteomic studies is 
that they are providing a detailed apoptotic mechanism and new potential AMD-related 
biomarkers. The global phosphoproteome changes in RPE cells under oxidative stress will 
help to identify key elements of phosphorylation signaling that serve as a framework of 
biochemical pathways of AMD progression. 
It is a critical question to understand the maintenance mechanism of appropriate 
phosphorylation signaling under chronic stress conditions. Oxidative stress may influence 
the expression of genetic risk factors, including complement factor H (CFH). Although the 
potential importance of protein phosphorylation/dephosphorylation as a therapeutic target 
has been appreciated, no detailed approach to date has been made targeting biomarkers in 
phosphoproteome to treat ocular diseases. For example, abnormalities in vimentin 
phosphorylation have been linked to neurodegenerative diseases, including AMD and 
Alzheimer’s disease [Madigan et al., 1994; Yen et al, 1983; Yu et al., 1994], but the 
phosphorylation network mechanism in RPE cells under oxidative stress remains largely 
elusive.  
Regulation of the phosphate on/off switch is a central tool for RPE cells to survive under 
stress conditions. Unbiased approach to determine phosphorylation sites and kinetics will 
help to understand the complex apoptotic network and epigenetic controlling mechanism of 
RPE death. A general proteomic approach that includes protein identification by mass 
spectrometry has been used routinely for the last decade, however, RPE phosphoproteomics 
remains challenging due to the complexity, substoichiometry (less than 50% 
phosphorylated), and kinetics (short vs. long time frame). Understanding phosphorylation 
in AMD is not clear, because protein phosphorylation is a very dynamic process, while the 
aging process is slow. Recent animal models exhibiting some of the features of human AMD 
 
Early Biosignature of Retina Degeneration 123 
are available, but most of these models do not represent the full spectrum of pathological 
changes observed in human AMD. Animal models that mimic the complex and progressive 
characteristics of AMD are extremely valuable for studying the pathogenesis of AMD and 
testing different treatment modalities. 
Phosphoproteins have been studied using chemical and affinity-based methods [Zhou et al., 
2008; Tao et al., 2005]. However, the rapid and dynamic nature of the underlying changes 
and the low abundance of phosphoproteins reflecting their substoichiometry present 
challenges to the quantitative study of the phosphoproteome. Thus, the isolation of the 
phosphoproteome or phosphopeptidome represents a potentially advanced step in this 
analysis. We introduced a system-wide, unbiased, and high-throughput approach to 
investigate global phosphoproteome of oxidative stress-induced or aged RPE and retinal 
cells using phosphoproteome enrichment and labeling method. Phosphoprotein-enriched 
extracts from human RPE cells under stress were separated by two-dimensional (2D) 
electrophoresis. Serine, threonine, and tyrosine phosphorylation were visualized by 2D 
phospho-Western blotting and specific phosphorylation sites were analyzed by tandem 
mass spectrometry. We examined phosphoproteome changes under oxidative stress in vitro 
and aging-induced phosphoproteome in vivo.  
Our results suggest a positive correlation between early biomarkers of phosphoproteome 
under oxidative stress and RPE proteins from AMD patients. The outcome of the current 
work is the initial delineation of the underlying physiology of oxidative stress-mediated 
phosphorylation signaling in RPE apoptosis. In addition, our study suggests a stimulus for 
understanding oxidative stress-induced cytoskeletal changes and the aggregate formation 
mechanism by phosphorylations. As a consequence, an effective therapeutic approach and 
animal model based on the modulation of phosphorylations are expected to result.  
Recently, pioneering proteomic profiling studies revealed protein expression changes in 
human RPE, drusen, and lipofuscin [West et al., 2001; Crabb et al., 2002; Schütt et al., 2007]. 
Other studies compared native differentiated to cultured dedifferentiated RPE cells [Alge et 
al., 2003; Alge et al., 2006]. Proteomics proved to be a useful tool in delineating changes in 
RPE with the progressive stages of AMD [Nordgaard et al., 2006; An et al., 2006; Norgaard 
et al., 2008], and diabetes [Decanini et al., 2007]. Also, proteomic tools were used to study 
changes in the vitreous humor associated with diabetic retinopathy [Kim et al., 2007] and 
retinal proteins in glaucoma model [Tezel et al., 2005]. Since oxidative stress is implicated in 
the etiology of several RPE diseases that include AMD, identification of molecular mediators 
and early signaling events under chronic stress is a crucial step for understanding cell death 
mechanism and retinal degeneration. However, limitations of proteomic approach, 
including minor proteins with low concentration, hydrophobic membrane proteins, 
reproducibility, and time and labor demanding processes, exist as huddles to get 
comprehensive details on the molecular mechanism. Moreover, there is no comprehensive 
database that could support the analysis of protein phosphorylation in human RPE from the 
standpoint of spatial and temporal changes. 
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Phosphorylation of specific amino acids, including serine, threonine, and tyrosine, is a 
significant modulator of protein function that regulates subcellular localization, protein–
protein interaction, conformational change, and signal transduction. Charge changes by 
phosphorylation creates a protein switch mechanism, allowing reversible phosphorylation 
to modify intracellular signaling in response to specific microenvironmental and genetic 
conditions and thereby act as a basic survival tool. However, the rapid and dynamic nature 
of the underlying changes and the low abundance of phosphoproteins reflecting their 
substoichiometry present challenges to the quantitative study of the phosphoproteome. The 
isolation of phosphoproteome or phosphopeptidome represents a potential challenge. Our 
data and other evidence suggest that phosphorylations are involved in apoptotic or 
protecting signaling under oxidative stress [Chung et al., 2009; Zhang et al., 2010; Arnouk et 
al., 2011; Lee et al., 2011; Sripathi et al., 2011].  
Proteomic study provides direct evidence and a molecular basis for phosphorylation 
signaling, cytoskeletal reorganization, and apoptotic mechanisms of AMD [Nordgaard et al., 
2006; Crabb et al., 2002; Ethen et al., 2006; An et al., 2006; Warburton et al., 2007]. A detailed 
proteome analysis of AMD supports our hypothesis that there is a positive correlation 
between RPE biomarkers under stress and AMD as shown in Table 1. 
To address the issue of phosphorylation in cytoskeletal reorganization, we examined 
morphologic and cytoskeletal changes of RPE cells under oxidative stress in vitro. The 
apoptotic cell surface changes initiate the protrusion, develop bubble-like blebs on their 
surface, and continue phagocytic alteration shown as the membrane disruption. In the 
middle stage, cells showed apical, basal and surface changes such as dense projection of 
microvilli. In later stage, cells broke into small, membrane-wrapped fragments.  
To examine potential markers corresponding cytoskeletal reorganization under oxidative 
stress, we examined vimentin, an intermediate filament protein shown in both control and 
AMD drusen [Crabb et al., 2002]. ARPE-19 contains retinal G-protein receptor (RGR) and 
peropsin as light detecting chromophore. Previous observation of vimentin in RPE cells 
derived from human choroidal neovascular membranes in AMD, as well as in drusen and 
melanolipofuscin, supporting our choice of phosphoproteome biomarkers in RPE cells 
under stress [Schlunck et al., 2002; Crabb et al., 2002; Warburton et al., 2007]. Previously, 
proteomic analysis of the retina revealed that the expression levels of vimentin and PP2A 
are significantly increased when C3HeB/FeJ mice (rd1 allele, 12 weeks, photoreceptor 
degenerated) are exposed under continuous light for 7 days compared to a condition of 12h 
light/dark cycling exposure [Zhang et al., 2010]. When melatonin is administered to animals 
while they are exposed to continuous light, the increased levels of vimentin and PP2A 
return to a normal level. Further, vimentin has been shown to be a target of PP2A that 
directly binds vimentin and dephosphorylates it. Vimentin is present in all mesenchymal 
cells, and often used as a differentiation marker. Like other intermediate filaments, vimentin 
acts to maintain cellular integrity; however, vimentin may play a role in RPE survival by 
phosphorylation. 
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AMD RPE 
proteome [1] 
AMD drusen
[2] 
RPE blebs [3] RPE proteome under OS
in vitro [4] 
RPE proteome 
under light  in 
vitro [5]  
ATP synthase 
 
CRABP1 
CRALBP 
Crystallin A 
Elf4H 
GST  
HSC 70 
HSP 60 
HSP 70 
Mt HSP 75 
Pyruvate 
kinase 
VDAC 1 
Annexin 5
Clusterin 
Complement 
component 9 
Crystallin B 
Crystallin A3 
Histone H2A2 
Serum albumin 
TIMP3 
Vimentin  
Vitronectin 
 
Annexin 5
Cytoskeleton-
associated protein 
4 
Desmin 
EF 1 
GST 
GTPase Rab 14 
HSP 70 9B 
Keratin 7, 18 
Lamin A/C 
MMP-14 
Peroxiredoxin 5 
Thioredoxin 
reductase 1 
Tubulin 
VDAC3 
Annexin 5
BUB3 
EF2 
GST  
Guanine binding protein  
HSP 90  
HSP 1 
Lamin A/C 
Peroxiredoxin 1, 2 
Phosphomevalonate kinase 
Plasminogen activator- 
inhibitor 1 
Prohibitin 
Pyruvate kinase 
Retinol binding protein 
RPE65 
Thioredoxin-dependent- 
peroxide reductase 3 
VDAC2 
Actin 
ATP synthase 
CRALBP 
Creatine kinase 
Crystallin A 
Crystallin B 
Crystallin B 
Crystallin  
G binding protein 
1 
HSP 70 
HSP 90 
HSP 1 
IRBP 
Plasminogen 
Protein kinase 4 
Pyruvate kinase 
RPE65 
Tubulin 1B 
Tubulin 2 
AMD retina 
proteome [6] 
RPE secretome
[7] 
AMD RPE 
secretome [7] 
Melanolipofuscin [8] Retina proteome 
in vitro under OS 
[9, 10] 
CRABP 
Crystallin A 
Crystallin B 
HSP 60 
HSP70 
Tubulin  
VDAC1 
 
Annexin 5
Caspase 5 
CFB 
CFH 
Complement C 
HSP 47 
Laminin 
MMP2 
Prasminogen 
activator 
inhibitor 1 
CFB
CFH 
Collagen  
Complement C 
Custerin 
Galectin 3 BP 
MMP2 
Annexin 5
ATP synthase 
Crystallin B 
G binding protein 
HSP 60 
HSP 70 
Prohibitin 
RBP 3 
RDH 11 
RDH 5 
RGR 
RPE65 
Tubulin  
Tubulin  
VDAC 1, 2, 3 
Vimentin 
Bcl-xL 
Caspase-3 
c-FOS 
Crystallin B 
Crstallin B 
Crystallin S 
Crystallin B 
Crystallin F 
EPO 
EPOR 
G binding protein 
Jak2 
Peroxiredoxin 2 
Peroxiredoxin 6 
PP2A 
Tubulin  
Vimentin 
[1] Nordgaard et al., 2006 [2] Crabb et al., 2002  [3] Alcazar et al., 2009 [4] Arnouk et al., 2011, [5] Lee et al., 2011, [6] 
Ethen et al., 2006 [7] An et al., 2006 [8] Warburton et al., 2007 [9] Chung et al., 2009 [10] Zhang et al., 2010 
Table 1. Comparison of AMD proteome vs. retina/RPE proteome changes under oxidative stress. Early 
biomarkers from our studies are in Italics. 
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Vimentin is a major component of intermediate filament that spread throughout the cell and 
serve as signal transducer conveying mechanical and molecular information from cell 
surface to nucleus and intracellular compartments. Modifications of vimentin are essential 
reactions of filament dynamics. Changes of vimentin phosphorylation are directed to 
reorganization of the intermediate filament network and altered function of RPE cells. 
Hyperphosphorylation of vimentin can disassemble intermediate filament into soluble 
monomeric form. Our results suggest that vimentin is critically involved in the process of 
light-induced damage in RPE cells. By reducing the light-induced post-translational 
modification of vimentin, PP2A may assist to maintain the proper filament network in RPE 
cells. 
Next we tested the hypothesis that oxidative stress may induce protein phosphorylation, 
including vimentin. Vimentin phosphorylation at S38 is downregulated under stress and is 
a potential PP2A specific site for dephosphorylation. Phosphorylation at S38 suggests a 
potential antiapoptotic role when considering increased Bak under oxidative stress. 
Phosphorylation at S55 under stress condition is upregulated compared to β-actin control. 
We examined whether normal light- induced phosphoproteome was altered in RPE cells. To 
investigate RPE phosphoproteome, we used 2D electrophoresis to separate proteins from 
cells incubated under light (7000 lux) or dark conditions for 1 hour. RPE proteins induced by 
light were visualized using mass spectrometry-compatible silver staining. MALDI-TOF-TOF 
mass spectrometry analysis revealed that a large proportion of the proteins up-regulated 
first and foremost by light in the RPE belong to the crystallin family. Our data demonstrated 
that crystallins were upregulated under oxidative stress in bovine primary RPE cells. Serine 
phosphorylation of crystallin was markedly increased in light exposure, as shown by pSer-
specific Western blotting. Notably, opposite effects on serine and tyrosine phosphorylation 
may yield positive or negative regulation with the same stimulus [Taniguchi et al., 2006]. 
Enzymes associated with phosphorylation or energy metabolism, including Ser/Thr protein 
kinase 4 (STE20) and ATP synthase, were downregulated under intense light. The most 
abundant light-induced upregulated phosphoproteins were crystallins, including A and 
B crystallins. Our results may suggest that phosphorylation of crystallin is critical to 
maintain a chaperone function in RPE cells. Phosphorylations at serine residues were next to 
proline or near proline. The results of phosphoproteome enrichment experiment were 
confirmed using an affinity-based phosphopeptide-enrichment strategy. In this experiment, 
in-solution trypsin digested peptides were concentrated using a metal (Ga+3) based column 
and analyzed by tandem mass analysis.  
Phosphorylation-dependent signaling might differ between tissues, and might reflect the 
microenvironmental diversity among different tissues, including differences in stress 
stimuli. Phosphoproteome change is an indication of an early signaling event under 
oxidative stress conditions in RPE. Increased phosphorylation of crystallins, in particular, 
might suggest a stress-response role for these proteins in the RPE. Accordingly, crystallin 
phosphorylation may provide an anti-apoptotic signal to attenuate oxidative stress-induced 
degenerative pathway as early signaling event. However, accumulated phoshprylated 
crystallins may lead to pathological mechanism [den Engelsman et al., 2005]. In this context, 
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stress-induced up- or down-regulation of crystallins is known to occur in various diseases or 
age-related conditions [Nordgaard et al., 2006; Ethen et al., 2006]. The functional 
relationship between heat-shock proteins and cytoskeletal proteins, such as intermediate 
filaments, vimentin and actin, is well documented [Clark et al., 2000; Xi et al., 2003]. N-
terminal phosphorylation of heat-shock proteins is correlated with the stabilization of 
cytoskeletal elements.  
Our studies support the hypothesis that a progressive accumulation of oxidative damage is 
a fundamental mechanism involved in RPE cell death. Oxidative stress occurs when free 
radicals produced in RPE cells are not completely modulated by the appropriate 
endogenous defense systems. Phospholipids are a major component that can be targeted by 
excess oxidative stress. Lipid peroxidation plays an important role in initiating and 
mediating phosphorylation and cell death signaling. Establishing the involvement of lipid 
changes in phosphorylation signaling has not been an easy task. The lipids of cellular 
membranes serve roles in controlling the structure and fluidity of the membrane, and as 
signaling molecules that modifies protein functions. The lipid binding assay demonstrated 
subcellular communication between mitochondria and the nucleus under oxidative stress. 
The changes in the expression and localization of p-crystallin and p-vimentin triggered by 
reactive oxygen species are crucial for RPE integrity. 
Recently, crystallin location and function in the retina and RPE have been described 
[Sakaguchi et al., 2003; Organisciak et al., 2011; Zigler et al., 2011; Sreekumar et al., 2010; 
Gangalum et al., 2011]. αA- and αB-crystallin are located in the ganglion cell layer and 
photoreceptor layer, whereas β-crystallin is detected in all nuclear layers of the retina [Xi et 
al., 2003]. The functional roles of crystallins as chaperones, anti-apoptotic proteins, or signal 
transducers in the retina have also been described [Xi et al., 2003; Sakaguchi et al., 2003; 
Kapphahn et al., 2003; Kim et al., 2007]. Phosphorylated αB-crystallin directly interacts with 
Bax and caspase-3 to suppress their pro-apoptotic action, and thus exerts a cytoprotective 
effect in the retina [Kim YH et al., 2007]. Light-induced up-regulation of αA-crystallin and 
increased phosphorylation of αA-crystallin in the aged retina have been reported 
[Kapphahn et al., 2003]. The specific function of each crystallin, particularly /β-crystallin in 
the RPE, is still largely unknown, although levels of αB-crystallin are increased after heat 
shock and oxidative stress, and αB-crystallin immunoreactivity has been found in both rod 
outer segments and the RPE after light exposure [Sakaguchi et al., 2003].  
3. Early proteome changes under oxidative stress 
Two-dimensional differential gel electrophoresis (2-D DIGE) is an advanced proteomic 
technique that labels minor protein samples with fluorescent dyes before 2-D 
electrophoresis. It enables accurate analysis of differences in protein concentrations between 
samples. DIGE method reduces experimental variations and technical errors. It is possible to 
separate up to three different samples within the same 2-D gel using three different 
fluorescent molecules. However, there are limitations of DIGE methods also, including 
covalent modifications on cysteine or lysine.  
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We used two different biological models that include primary bovine RPE cells and human 
RPE cell line D407, to uncover differential biosignatures under oxidative stress [Davis et al., 
1995]. We employed a combination of proteomic technologies, including sensitive 
fluorescent labeling and TOF-TOF mass spectrometry analysis with high mass accuracy and 
low tolerance in the range of 50 ppm (0.05 Dalton). Identified proteins were confirmed by 
quantitative Western blotting. We observed expression changes of cellular signaling related 
molecules, including intermediate filament, retinoid metabolism, energy metabolism, and 
antioxidant proteins in bovine RPE cells. Several intermediate filament components, 
including neurofilament H, M, L proteins and glial fibrillary acidic protein, were up-
regulated in bovine RPE cells. Intermediate filament proteins are cytoskeletal components 
that form fibrils with an average diameter of 10 nm. Neurofilament H, M, and L proteins are 
specifically expressed in neurons. Glial fibrillary acidic protein is a biomarker in glial cells. 
Previous studies showed that environmental changes, such as culture conditions, could 
induce dedifferentiation of RPE cells and give rise to mesenchymal-like cells.  
Proteome changes related to energy metabolism were also observed under oxidative stress 
in bovine RPE cells. Pyruvate dehydrogenase E1 transforms pyruvate into acetyl-CoA that is 
used in the citric acid cycle to generate ATP. Pyruvate kinase M1 transfers a phosphate 
group from phosphoenolpyruvate (PEP) to adenosine diphosphate (ADP), to synthesize 
ATP and pyruvate. Up-regulation of both enzymes may indicate higher energy 
consumption to compensate oxidative stress-induced faster turnover of proteins in the RPE.  
In RPE D407 cells, several molecular chaperones were altered as a result of H2O2 treatment. 
Hsp 90α and Hsp β1 exhibit general protective chaperone properties such as preventing 
unspecific aggregation of non-native proteins. Calreticulin, up-regulated in bovine RPE 
cells, is a multifunctional protein that binds to Ca2+ and misfolded proteins to export them 
from the endoplasmic reticulum (ER) to the Golgi apparatus. Elimination of misfolded 
proteins in the ER affects cellular homeostasis and survival, so chaperone function of heat 
shock proteins is indispensible under stress conditions.  
Retinoid metabolism in primary bovine RPE cells is altered under oxidative stress 
conditions. Photosensitivity and the steady state of retinoid concentrations are controlled by 
regeneration of 11-cis-retinoid, which is called the visual cycle. RPE65, a peripheral 
membrane protein of RPE cells, is an all-trans-retinyl ester isomerohydrolase. Indeed, we 
showed that RPE65 in bovine RPE is up-regulated under oxidative stress. Our data 
demonstrated that RPE65 is cleaved into a 45 kDa and 20 kDa truncation forms under 
oxidative stress. This data indicates that oxidative stress can influence the visual cycle by 
up-regulation of RPE65 and cleavage of this protein. Further studies of whether this 
truncated form might be a biomarker of oxidative stress are currently under investigation. It 
seems that immortalized human RPE cells suppress RPE65 expressions as a basic regulatory 
mechanism for the visual cycle that is not essential for survival. Prohibitin, a mitochondrial 
chaperone involved in oxidative stress and aging, was found to be downregulated under 
oxidative stress in primary bovine RPE cells.   
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Antioxidant proteins were upregulated under oxidative stress. Peroxiredoxin is a ubiquitous 
family of antioxidant enzymes that can be regulated by changes of redox potential in the 
cell. Thioredoxin-dependent peroxide reductase is an antioxidant enzyme that provides 
protection mechanism against oxidative stress. It reduces H2O2 by hydride provided by 
thioredoxin, thioredoxin reductase, and NADPH. Upregulation of antioxidants can regulate 
redox homeostasis in RPE cells and thus protect cells from oxidative stress-induced damage.  
Both biological models using primary bovine RPE cells and immortalized D407 cells have 
advantages and limitations. We observed differences in protein expressions correlated with 
oxidative stress in two biological models used in our study, which can be attributed, at least 
partially, to the inherent differences in two different RPE cell types. It has been reported that 
cytoskeletal remodeling and cell survival factors are differentially expressed in primary 
culture and immortalized human RPE cells. Dedifferentiated, immortalized human RPE 
cells results in down-regulation of specific proteins associated with retinoid metabolism. At 
the same time, they induce the differential expressions related with cytoskeletal 
organization, cell shape, migration, and proliferation. Thus, we speculate that two different 
proteome list in two different systems such as primary bovine vs. immortalized human RPE 
cells is due to different cell type and not due to species difference or detection system. 
Oxidative stress alone is the major risk factor of retinal degeneration compared to genetic 
risk factors. Furthermore, oxidative stress may influence the expression of genetic risk 
factor, such as complement factor H (CFH). Cellular processes induced by oxidative stress in 
RPE cells and the molecular mechanisms under the oxidative stress that contribute to retinal 
degeneration are not clear at this point. We revealed several expression changes in the RPE 
proteome that is induced by H2O2 treatment. Targeting early signaling proteins is a useful 
therapeutic strategy for the treatment of degenerative diseases of the retina and the RPE. 
4. Prohibitin as a new oxidative stress biomarker 
It is estimated that every ten minutes in the USA someone becomes blind. More than 4 
million Americans have age-related macular degeneration (AMD), the most common cause 
of legal blindness in those older than fifty five. Even though the role of abnormal 
angiogenesis in the pathogenesis of AMD has been recently established, we still do not 
know why the macular deteriorates and why AMD progresses. Our proteomic experiments 
demonstrate that prohibitin is a shuttling protein primarily expressed in mitochondria, 
however, it translocalizes to the nucleus under oxidative stress. The extent of prohibitin 
localization in mitochondria inversely correlates with levels of oxidative stress.  
Our knockdown approach suggests that prohibitin may have the anti-apoptotic function 
through Bcl-xL and mitochondrial DNA binding mechanisms. Our data further  
suggests that specific lipid-binding mechanisms involving altered cardiolipin interactions 
might be the key element to determine prohibitin shuttling between mitochondria and the 
nucleus. Mitochondrial dysfunction is associated with AMD and our preliminary studies 
also suggest specific pathophysiological mechanisms involving altered mitochondrial 
disruption.    
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Prohibitin is involved in the alternative pathway of complement C activation. However, the 
regulatory mechanisms are elusive. Prohibitin is subjected to various post-translational 
modifications under growth factor stimulation and oxidative stress. Prohibitin induces a 
conformational change that enhances activation of C3. 
Prohibitin is originally known as an anti-proliferative protein [McClung et al., 1989]. It is 
highly conserved from bacteria to human [Asamoto and Cohen SM, 1994], but its function is 
not clearly understood. Prohibitin was proposed to have a role as a cell cycle inhibitor 
[Nuell et al, 1991; McClung et al, 1995], a transcriptional regulator [Wang et al, 1999a; Wang 
et al, 1999b], an inflammatory modulator [Sharma and Qadri, 2004], a plasma membrane 
receptor [Kolonin et al, 2004], and a mitochondrial chaperone [Nijtmans et al, 2000; Artal-
Sanz et al, 2003; Steglich et al, 1999]. Its chaperone function in mitochondria has recently 
received more attention as a modulator that responds to oxidative stress [Coates et al., 2001]. 
Prohibitin is involved in apoptosis and aging by stabilizing newly synthesized respiratory 
enzymes [Bourges et al, 2004; Nijtmans et al, 2002], however, its presence and function in the 
eye has never been studied. Our studies demonstrate that prohibitin is a novel protein that 
shuttles between mitochondria and the nucleus as an anti-apoptotic chaperone as well as a 
transcriptional regulator under oxidative stress [Arnouk, et al., 2011; Lee et al., 2010; 
Srinivas et al., 2011]. 
Prohibitin undergoes phosphorylation at multiple residues under various cellular condition 
or in response to various stimuli. Phosphorylation of prohibitin facilitate its interaction with 
SH2 domain containing phospho tyrosine phosphatases Shp1 and Shp2. In a separate study, 
prohibitin was identified as a substrate for Akt and it has been shown that Akt induced 
prohibitin phosphorylation at threonine258. While these studies have clearly shown that 
prohibitin is phosphorylated at multiple residues, however, conditions under which these 
residues are phosphorylated and functional consequences are not clear. Prohibitin binding 
proteins were apoptosis related (Bcl-2 like protein), cholesterol homeostasis (PI4K5, 
diacylglycerol kinase, apolipoprotein B48 receptor, VLDLR), nucleotide binding proteins 
(guanine exchange factor, endonuclease, cell cycle regulator) and a complement component 
(Table 2).   
5. Anti-apoptotic prohibitin function in mitochondria  
We performed loss of function studies using prohibitin-specific small interfering RNA 
(siRNA) to demonstrate an increase of apoptotic signaling when prohibitin was knockdown. 
We tested two siRNA constructs that inhibit prohibitin expression compared to a control 
siRNA that has a random sequence. A solvent vehicle was used as the second negative 
control also. We chose conditions when prohibitin expressions were reduced by 80-90% 
compared to random sequence control. We examined whether prohibitin knockdown 
activates pro-apoptotic AIF, BAK, and caspases. Prohibitin knockdown may control other 
anti-apoptotic molecules also. Indeed, pro-apoptotic AIF, caspase-9, and BAK increased 
under prohibitin knockdown condition whereas anti-apoptotic Bcl-xL decreased. Also we 
examined decreased prohibitin condition cleaves poly (ADP ribose) polymerase (PARP) as a  
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Prohibitin binding proteins MW/pI Function 
Vav-1 guanine exchange factor 98 kDa/6.2 proto-oncogene 
ATP binding cassette 4 66 kDa/6.9 regulator of cAMP level 
DEAD box 32 84 kDa/5.0 RNA helicase 
epithelial cell transforming 2 104 kDa/7.5 oncogene 
guanine exchange factor 119 kDa/5.9 activation of GTPases 
Transglutaminase 93 kDa/6.5 protein aggregation 
phosphoinositol-4-phosphate 5 kinase 45 kDa/9.6 
epithelial cell morphology 
actin polymerization 
Nei Endonuclease VIII like protein 1 37 kDa/9.2 DNA excision repair 
Bcl-2 like protein 14 37 kDa/7.7 apoptosis facilitator 
calpastatin 76 kDa/4.9 calpain inhibitor 
complement component C6 105 kDa/6.7 membrane complex 
cell cycle regulator Mat89Bb homolog 80 kDa/6.2 nucleus-centrosome coupling 
diacylglycerol kinase zeta 103 kDa/9.8 phosphatidic acid synthesis 
Apolipoportein B48 receptor-like 109 kDa/4.4 carrying cholesterol to tissues 
very low density lipoprotein receptor 93 kDa/4.7 regulator of cholesterol levels 
Table 2. Prohibitin binding proteins determined by immunoprecipitation. 
pro-apoptotic marker because PARP cleavage is an early marker of caspase activation. 
Transfection of siRNA of prohibitin into ARPE-19 cells resulted in increased cleavage of 
PARP which represents that an apoptotic signal is induced when prohibitin is down-
regulated.  
Next we examined whether caspases are also activated as essential markers in apoptosis. 
The activation of caspase-9, one of the upstream regulators in apoptosis, showed early 
apoptotic signaling under prohibitin knockdown condition. Our results suggest that 
knockdown of prohibitin increases caspase-dependent apoptotic signaling. This data implies 
that prohibitin may act as an anti-apoptotic protein in mitochondria by forming a functional 
complex with other apoptotic proteins. Prohibitin concentration is inversely correlated with 
the initiation of apoptosis. Then we asked whether decreased prohibitin disrupts the 
filamentous reticular network of mitochondria resulting in fragmented mitochondria. 
Immunocytochemical analysis showed that prohibitin knockdown led to accumulation of 
fragmented mitochondria. Then we asked whether expression and localization of prohibitin 
is altered under stress condition.  
Emerging evidence suggest that oxidative stress and associated local upregulation of 
alternative pathway of complement may play a critical role in the progression of AMD. 
However, the link between oxidative stress. Altered prohibitin function may be a connecting 
link between oxidative stress and complement activation in AMD. Our studies demonstrate 
that prohibitin expression in the RPE is altered under oxidative stress in vitro and in vivo. We 
tested an advanced proteomic approach using a 2D differential gel electrophoresis (DIGE) 
technique to label RPE proteome by fluorescent molecules to uncover new biomarkers 
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under stress conditions. We found that prohibitin is a chaperone molecule maintaining 
mitochondrial structure and function shown by immunoprecipitation and knockdown 
method.  
We have been actively seeking early molecular signaling events under oxidative stress in the 
retina and RPE using a proteomics and metabolomics approach to identify new biomarkers. 
This approach demonstrated that prohibitin is involved in oxidative stress signaling in vitro 
and in vivo [Lee et al., 2010b; Arnouk et al., 2011; Srinivas et al., 2011]. Prohibitin was 
proposed as an anti-proliferative protein or a tumor suppressor forming a high molecular 
complex with prohibitin2 in mitochondria [Steglich et al., 1999]. Localization of prohibitin 
has been controversial, possibly being mitochondrial, nuclear, or cell surface [Wang et al., 
2002; Rivera-Milla et al., 2006].  
We examined the cellular localization of prohibitin which is a controversial question. 
Confluent ARPE19 cells were treated with 200 µM H2O2 for 24 hrs and prohibitin 
localization in response to oxidative stress was investigated using immunocytochemistry. 
Subcellular organelles and prohibitin were visualized by DAPI (nuclear DNA, blue,  
369/460 nm absorbance/emission), MitoTracker (mitochondria, red, 578/599 nm 
absorbance/emission), and Alexa-488 (prohibitin, green, 495/519 nm absorbance/emission), 
by taking three color fluorescent images every hour. This kinetic assay confirmed that the 
signaling pathway was involved in prohibitin transit to the nucleus from mitochondria. 
H2O2 treated cells showed nuclear translocalization of prohibitin, whereas untreated cells 
showed localization in mitochondria. After 8 hrs, prohibitin showed an accumulation in the 
nucleus as compared to the control group. After 24 hrs, more nuclear prohibitin was 
observed and prohibitin didn’t show as much colocalization with mitochondria.  
To answer whether prohibitin is modified under stress condition, we tested the correlation 
between oxidative stress and the ratio of soluble vs. membrane-binding prohibitin. Because 
prohibitin may exist in both detergent-resistant and soluble fractions, we tried to separate 
prohibitins by longer running time SDS-PAGE. Soluble prohibitin in the cytosolic fraction 
moved faster when compared to membrane-bound mitochondrial and microsomal 
prohibitin. Detergent-resistant, membrane-binding prohibitin showed slightly higher 
molecular weight when compared to soluble prohibitin. We found that the ratio of soluble 
prohibitin to membrane binding prohibitin decreased under oxidative stress. Under stress 
condition, soluble prohibitin decreased and membrane-binding prohibitin increased. To 
answer how long this trend would last under oxidative stress, we performed a kinetic assay 
under oxidative stress. After 6 hrs, the soluble prohibitin level returned to its control level. It 
is possible that the membrane-binding and soluble form exists in different subcellular 
organelles, so we next examined the subcellular localization of prohibitin by fractionation.  
Membrane-binding prohibitin showed slightly higher molecular weight when compared to 
soluble prohibitin. We examined the correlation between oxidative stress and soluble vs. 
membrane-binding prohibitin and found that the ratio of soluble prohibitin to membrane 
binding prohibitin decreased under oxidative stress. Soluble prohibitin decreased and 
membrane-binding prohibitin increased under stress condition. Then we tested how long 
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this trend would last under oxidative stress. After 6 hrs, the soluble prohibitin level returned 
to its control level. It is possible that the membrane-binding and soluble form exists in 
different subcellular organelles, so we examined whether prohibitin binds a mitochondrial 
specific phospholipid, cardiolipin.  
6. Prohibitin binds cardiolipin under oxidative stress  
We asked whether prohibitin localization could be controlled by membrane lipid binding. 
We speculated that the localization and trafficking of prohibitin might be determined by 
mitochondrial-specific lipid such as cardiolipin. Lipid interaction assay demonstrated that 
mitochondrial prohibitin has a strong affinity at low cardiolipin concentration whereas 
nuclear prohibitin showed a much weaker affinity to cardiolipin, interacting at higher 
concentrations. Lipid analysis in ARPE-19 cells by mass spectrometry demonstrated that 
cardiolipin concentration decreased 20-70% under 200 M H2O2. 
This result suggests that membrane lipid and modification may determine prohibitin 
localization under oxidative stress. When cardiolipin concentration is low under oxidative 
stress, prohibitin moves to the nucleus. Then we tested whether prohibitin may have 
preference toward specific lipids when prohibitin is a limiting factor. Under normal 
condition, prohibitin from ARPE-19 cells demonstrated a strong interaction with 
phosphatidylinositol 3,4,5 triphosphate (PIP3), PIP2, PIP, and 3-sulfogalactosylceramide, but 
not with cardiolipin. Lipid binding affinity changed dramatically under oxidative stress. 
Prohibitin under stress showed a strong affinity toward cardiolipin, phosphatidylserine, and 
phosphatidic acid. This observation led us to conclude that prohibitin has an affinity 
towards negatively charged phospholipids, especially cardiolipin under oxidative stress.  
To examine prohibitin response under oxidative stress in detail, we then examined protein 
expression level changes in vitro using ARPE-19 cells. We examined whether prohibitin level 
changes under H2O2 in time and dose dependent manner. Protein analysis by SDS-PAGE 
and Western blot demonstrated that prohibitin is down-regulated under oxidative stress 
(50-200 M H2O2, 1-24 hrs). Cells treated with 200 M H2O2 showed a 40% decrease of 
prohibitin, but the levels between treated groups in 24 hrs revealed no significant difference 
by t-test, indicating that decreased levels of prohibitin under oxidative stress is an acute 
process that occurs within 2 hrs. This result suggests that the nuclear prohibitin may not be 
a newly synthesized protein as there was no prohibitin increase for 24 hrs; instead the 
nuclear prohibitin might be derived from mitochondria since prohibitin was not colocalized 
with mitochondria after extended H2O2 treatment. 
Our previous in vivo experiments suggest that prohibitin may respond differently in the retina 
and RPE under oxidative stress conditions, including diabetes and aging. To specify the 
location of prohibitin in cells, we separated subcellular fractions using serial centrifugations, 
specific detergents, and polyamines. Subcellular proteins were separated into soluble and 
insoluble nuclear and mitochondrial proteins as well as cytosolic and microsomal fractions. 
Denatured and native gel electrophoresis, followed by Western blot of subcellular organelle 
showed that prohibitin is widely distributed in cells but is centralized in mitochondria.  
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In mitochondrial fraction, prohibitin showed 32 kDa molecular weight and pI=5.6 as 
expected. Prohibitin was more acidic in the nucleus showing pI=5.3, possibly due to post-
translational modifications such as phosphorylation. Mass spectrometry analysis revealed 
that S101 and S151 sites are phosphorylated. Cytosolic prohibitin showed very basic spots of 
pI=6-7 and higher molecular weight as shown in the box.  
As each subcellular prohibitin showed different pI values in 2D electrophoresis, we 
examined potential post-translational modifications, including phosphorylation. Each 
fraction was separated by electrophoresis and prohibitin was visualized by Western blot 
using prohibitin and phospho-serine (pSer) antibodies. Only the nuclear fraction showed 
phosphorylated prohibitin shown by pSer Western blot. Mitochondrial, cytosolic, and 
microsomal prohibitin did not show phosphorylation. To confirm this data, we performed 
native gel electrophoresis and received the same result. 
7. Neuroprotective erythropoietin (EPO) 
Apoptosis is the primary mechanism that results in the abnormal death of photoreceptors, 
retinal ganglion cells (RGC), or retinal pigment epithelial cells (RPE) in degenerative retinal 
diseases, including age-related macular degeneration (AMD), retinitis pigmentosa (RP), and 
glaucoma. Light insults result in increased production of reactive oxygen and nitrogen species 
that include hydrogen peroxide and nitric oxide, which are involved in an early event of 
retinal degeneration. In response to intense or constant light triggers, neuroprotective proteins 
provide an antiapoptotic effect to protect retinal and retinal pigment epithelial (RPE) cells, 
however, the mechanisms remain elusive. Thus there is a critical need for understanding the 
intrinsic neuroprotective mechanisms that prevents apoptotic cell death. Our studies suggest 
that potential degeneration signaling may result from expression changes and 
phosphorylations of key proteins of EPO downstream. EPO down-regulates caspases and 
intense light up-regulates caspases, which imply that depleting EPO is one of the major light 
effects that can cause changes in protein expression through anti-apoptotic mechanisms.  
We demonstrated that the retinal expression of EPO and subsequent phosphorylation of 
Jak2 and Stat3 are tightly linked to the circadian clock after oxidative stress and in 
anticipation of daily light onset. Our data suggest that the neuroprotective effects of EPO 
might be involved the regulation of apoptotic signaling molecules, including Bcl-xL, and 
caspase-3. In the RPE, NO was proposed as a secondary messenger in phagocytosis. 
Interdependent regulation of NO and EPO has not been examined, even though recent 
studies imply potential interactions of NO-EPO through the Hif1a pathway.  
Retinal injury due to light occurs through oxidative mechanisms. Recently we demonstrated 
that the recycling reactions of 11-cis-retinal, called the visual cycle, is circadian coordinated  
to effectively protect the retina from the detrimental effects of light-induced and oxygen-
dependent damage [Chung et al., 2009, Lee et al., 2010a]. Our data suggested that the retinal 
expression of EPO and its receptor (EPOR), as well as subsequent Janus kinase 2 (Jak2) 
phosphorylations, are tightly linked to a time window after oxidative stress and in 
anticipation of daily light onset. This is consistent with physiological protection against 
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daily light-induced, oxidative mediated apoptosis [Hardeland et al., 2003; Hrushesky 1985; 
Scheving et al., 1988; Smaaland et al., 1991; Smaaland et al., 1992].  
We found that nitric oxide (NO) was generated in RPE cells under light exposure. NO is 
related to the inhibition of ischemic injury and plays a key role in the delayed cell death 
following transient retinal ischemia. Thus, NO is proposed as a neuroprotective molecule or 
neurotoxic reagent based on its local concentration. In the RPE, NO was proposed as a 
second messenger in phagocytosis. Interdependent regulation of nitric oxide and EPO has 
not been examined, even though recent studies imply potential interactions of NO-EPO 
through either HIF1a or arginine metabolism. Appropriate levels of nitric oxide (NO) may 
cause up-regulation of EPO/EPOR in RPE and thereby assist in limiting retinal degeneration.  
EPO has been extensively studied for its neuroprotective role for the past 10 years, but the 
regulation mechanisms have not been understood at the molecular level [Brines and Cerami, 
2005; Calapai et al., 2000; Jelkmann 2007; Kanaan et al., 2006; Kawakami et al., 2001; Li et al., 
2007; Mauer 1965; Miyake et al., 1977; Yamaji et al., 1996; Zhong et al., 2007]. Previous 
approaches using the in vivo mice model was not satisfactory, because the EPO knockout 
mice model is lethal. No approach to date has been effective in moving beyond the addition 
of EPO in vitro and in vivo.  
The in vivo erythropoietic effects of administered EPO are known to depend upon the time 
of administration [Wood et al, 1998; Bellamy et al., 1988]. Moreover, elevated EPO levels 
during the proliferative stage may contribute to neovascularization and accelerate 
pathological angiogenesis, in which EPO showed little therapeutic effect at later stages of 
retinopathy [Chen et al., 2008]. Light kills retinal cells. In response to light, neuroprotective 
proteins trigger an anti-apoptotic pathway in the retina to protect cells from light-induced 
oxidative stress. However, the mechanism that regulates expression of these retinal proteins 
remains elusive.  
Erythropoietin (EPO) is an oxygen-dependent hematopoietic cytokine that stimulates the 
proliferation, differentiation, and survival of erythroid progenitor cells. EPO protects cells 
from neuronal damage, including experimental central nervous system models of hypoxic 
and ischemic insults [Jelkmann and Metzen, 1996; Jelkmann, 2005]. Oxygen dependent 
mechanisms are derived from models such as traumatic brain injury [Brines et al., 2000], 
spinal cord injury [Celik et al., 2002], Parkinson’s disease [Kanaan et al., 2006], excitotoxicity 
[Kawakami et al., 2001; Morishita et al., 1997], oxidative stress [Calapai et al., 2000] and 
chemical neurotoxicity [Genc et al., 2001]. EPO can protect retinal ganglion cells (RGCs) 
from degeneration induced by acute ischemia reperfusion injury [Liu XT et al., 2006] and 
axotomy injury [Weishaupt et al., 2004]. 
EPO promotes survival of RGCs in a glaucoma mouse model [Zhong et al., 2007], and 
stimulates neurogenesis and post-stroke recovery [Tsai et al., 2006]. In vitro models reveal 
that EPO stimulates neuritic outgrowth by postnatal [Böcker-Meffert et al., 2002] and adult 
RGCs [Kretz et al., 2005]. EPO is produced in the retina in response to acute hypoxia via Hif-
1α stabilization, which confers protection from light-induced retinal degeneration [Grimm 
et al., 2002]. The specific role of EPO was emphasized in that only EPO gene expression was 
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significantly affected among various angiogenic factors in Hif-1a-Like Factor (HLF) 
knockdown model [Morita et al., 2003].  
However, controversial discussions of EPO in retinal neuroprotection exist. Understanding 
EPO function in pathological angiogenesis is critical to timing for intervention [Chen et al., 
2008]. Our studies demonstrated that EPO and EPOR interactions represent an important 
retinal shield from physiologic and pathologic light-induced oxidative injury. 
To test the hypothesis that EPO is regulated by light in vivo, retinas from mice subjected to 
normal 12 h light/dark cycle were accessed for EPO and EPOR protein content. Retinal EPO 
increased for 2 h after the light turned on and gradually declined in the late light phase. 
However, 2 h before the light returned, EPO increased. The 24 h pattern of EPOR followed a 
similar pattern to EPO. This result suggests that the endogenous circadian clock may 
regulate EPO and EPOR levels such that they increase just before light onset in anticipation 
of the daily light period (L/D 22 h). However, under constant dark condition (D/D 22 h), 
EPO/EPOR were not upregulated.  
Our data demonstrated that the circadian organization of retinal EPO and EPOR elaboration 
is a potentially effective endogenous physiologic strategy for retinal protection from light-
induced, oxygen-mediated damage. These findings are consistent with documented 
circadian regulation of the full range of oxidative damage protecting enzymes or 
antioxidants, including glutathione (GSH/GSSG).  
Then, we tested the hypothesis that oxidative stress, including intense light, hypoxia, and 
hyperoxia, may induce EPO response in the retina in vitro. As early as 15 min after light 
exposure in retinal cells, EPO expression increased. Immunoblots showed that expressions 
of EPO increased 1 h after exposure to hypoxia and hyperoxia. In retinal and RPE cells, cells 
appeared morphologically viable, and no cell death was noticed for 6 hrs under hypoxic and 
hyperoxic conditions. Under oxidative stress, upregulation of EPO confers a neuroprotective 
function against retinal degeneration. Our aim was to explicate the role of the light and 
oxidative stress in the control of neuroprotective EPO expression in the retina and RPE.  
We treated EPO (50-200 U) on rat retinal cells and human RPE cells in vitro under oxidative 
stress to examine its protective effect. EPO inhibited caspase-3 activation in retinal cells 
under stress, indicating that EPO is anti-apoptotic.  
As an endpoint analysis, we performed a cell viability assay using a rat retina and human 
primary RPE cell culture treated with H2O2 as an oxidative stress model for a control 
experiment. At a concentration of 20 µM or higher for 3 hrs, H2O2 exerted significant toxicity 
to retinal cell cultures. H2O2-induced retinal cell death was reduced to 40, 46, or 43 %, 
respectively, by 30 min pretreatment of 50 units of EPO with 40 µM H2O2 for 6, 12, and 24 
hrs. In contrast, only a mild protective effect (15%) was observed in the RPE exposed to 
H2O2 by EPO treatment in 24 hrs.  
To see the protective effect in the RPE, a high dose of EPO (up to 200 U) was required, and 
was found mildly toxic to the RPE cells. Phase-contrast photomicrographs showed that no 
significant cell death occurred in sham-washed control or treated human RPE cells with 400 
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µM H2O2 for 12 h. Cell viability was assessed by the amount of lactate dehydrogenase 
(LDH) release measured from the medium of RPE cultures exposed to H2O2 for 3, 6, 12, and 
24 hrs.  
EPO is a powerful cytoprotective protein against apoptosis. However, elevated levels of 
EPO are found in the vitreous due to proliferative diabetic retinopathy [Katsura et al., 2005; 
Watanabe et al., 2005]. In addition, high dose of EPO increased the risk of cardiovascular 
disease and tumor growth [Singh et al., 2006; Bohlius et al., 2006]. 
These studies suggest a role of EPO in pathological retinal angiogenesis. The effects of EPO 
on angiogenesis are not well understood and the role of EPO in vascular stability is not 
clear. Understanding the functional role of EPO on angiogenesis is beneficial to patients 
with diabetic retinopathy (DR) and retinopathy of prematurity (ROP). EPO has been known 
to promote endothelial cell proliferation and vessel growth, however, the influence of EPO 
on apoptotic signaling and retinopathy is beginning to be understood. To determine the 
effects of EPO on vessel growth, we explored downstream regulators of EPO under normal 
physiological condition. VEGFR1 and angiotensin I/II as two major angiogenic factors were 
examined. VEGFR1 in the retina and angiotensin I/II in RPE increased after EPO treatment 
(100 U) in 6-12 h, respectively.  
Our study suggests that the role of EPO in the development of initial vessel loss via 
VEGF/VEGFR/angiotensin signaling. This signaling is important in understanding retinal 
vessel loss that is initiated prior to neovascularization. The initial vessel loss determines the 
severity of neovascularization. VEGF was downregulated upon EPO knockdown in RPE 
cells, which may suggest that EPO and VEGF expression is regulated in parallel, and they 
may interact directly or indirectly.  
EPO induces the proangiogenic phenotype in rat retina and human RPE cells. Addition of EPO 
correlates with the progression of VEGFR and AngiotensinI/II, which suggests that EPO might 
be an endogenous stimulant of vessel growth during retinal angiogenesis and in the 
development of neovascularization. Possibly, EPO mediates the renin-angiotensin system 
(RAS) which may promote neovascularization through local changes in blood flow and 
production of VEGF. EPO is considered as a proinflammatory agent since it triggers the 
expression of angiotensin I/II, which may act as an inflammatory agent by enhancing vascular 
permeability through VEGF. We examined whether the EPO-dependent pathway is up-
regulated or down-regulated in various oxygen-imbalance conditions. Along with increased 
levels of EPO after light exposure, levels of rhodopsin in retinal cells increased as early as 15 
min after 5000 lux light exposure in a time-dependent manner. RPE65 cleavage increased after 
15 min exposure to 5000 lux light in the RPE. Immunoblots for Bcl-xL and c-Fos showed that 
the neuroprotective effects of EPO may involve upregulation of these early markers in stress-
induced condition. Anti-apoptotic Bcl-xL and c-Fos were also up-regulated in the light. EPO-
mediated neuroprotective effects attribute to interaction with Jak2, Bcl-xL, and c-Fos. Other 
downstream regulators such as Stat3 might be required for anti-apoptotic Bcl-xL induction as 
shown in the motor neuron [Schweizer et al, 2002]. Jak2 and Stat3 phosphorylations in retinal 
and RPE cells increased under hypoxia, hyperoxia, and light exposure. 
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Proangiogenic protein VEGF is up-regulated under hypoxic conditions in the retina and the 
RPE. Our data demonstrated that EPO and VEGF expressions are regulated in parallel, and 
they may interact directly or indirectly. We will test our hypothesis that pro-angiogenic 
signaling of VEGF regulated by EPO. 
EPO and EPOR had a similar pattern of distribution in both neurons and astrocytes. Within 
3 hrs after exposure to hypoxia, expression of EPO and EPOR in various retinal cells 
increased. The number of co-localized cells with EPO/EPOR with retinal cell markers also 
increased in 1% O2 hypoxic condition. Relative levels of EPO mRNA were determined by 
real time-PCR in hypoxia. An elevated EPO level was detected after exposure of primary 
retinal cells to hypoxia (1% O2) with 6-fold up-regulation after 12 h. We observed intense 
light induced up-regulation of c-Fos, Bcl-xL, thioredoxin pJak2, pSTAT3 in early passage of 
human RPE cells. Rat retina cells under bright light up-regulated pJak2, EPO, and EPOR in 
an hour. pJak2 and pStat3 in the RPE increased in hypoxic condition (1% O2). 
Phosphorylation of Jak2 and Stat3 was confirmed as shown by phospho-Western blot. As an 
upstream regulator of EPO, HIF-1a was examined. HIF-1a increased in light, hyperoxic, and 
hypoxic conditions.  
8. Cytoskeletal reorganization under oxidative stress 
Not only intense light but also constant moderate light may trigger induction of anti-
apoptotic Bcl-xL, EPO, and pro-apoptotic caspases. We postulate that light may induce post-
translational modifications of target proteins. Previously, we identified that serine/threonine 
protein phosphatase 2A (PP2A) is induced and modified under constant light in vivo.  
To our knowledge, protein nitration mechanism under various oxidative environmental 
conditions, including intense light and continuous light, has never been studied in retinal 
cell cultures, RPE cells, or mouse model system. Our contribution here is expected to be a 
detailed understanding of how PP2A modification of a subunit is regulated by endogenous 
signaling molecule, nitric oxide (NO). PP2A and vimentin might be critically involved in the 
process of light-induced retinal and RPE cell damage. It is expected that what is learned will 
be equally applicable to anti-apoptotic mechanism. In addition, the research will be of 
significance because what is learned will contribute to broader understanding of how other 
phosphatase activity can be modulated as an approach to therapy.  
Although the potential importance of protein dephosphorylation as a therapeutic target has 
been appreciated, no detailed approach has been made targeting PP2A. Abnormalities in 
PP2A activity and concentrations have been linked to neurodegenerative diseases, including 
Alzheimer’s and Parkinson’s. The mechanism by which PP2A activity is regulated under 
oxidative stress remains largely elusive. Despite recent advances on structural investigation 
of PP2A, comprehensive understanding of dephosphorylation mechanism is far from 
complete.  
Our data suggests that PP2A and vimentin are critically involved in the process of light-
induced damage in the retina and RPE. By modulation of light-induced post-translational 
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modifications of PP2A, vimentin may assist in maintaining the proper filament network in 
Müller cells, which subsequently supports neuronal survival and architecture in the retina. 
Dephosphorylation switch by tyrosine nitration will provide new targets for therapeutic 
interactions in apoptosis-mediated disorders.  
Light-induced photoreceptor damage depends on the functional visual cycle, a biochemical 
regeneration of 11-cis-retinal chromophore. The induction of light damage depends on the 
light condition; acute damage by intense light requires rhodopsin bleaching, whereas 
constant moderate light involves phototransduction. Recently we showed that the visual 
cycle is coordinated in a circadian manner as a means of effectively protecting the retina 
from the detrimental effects of light-induced, oxygen-dependent, free-radical-mediated 
damage, especially at the times of day when light is more intense [Chung et al, 2009]. RPE65 
defects are known to trigger a remodeling of the retina that disrupt photoreceptor 
homeostasis and induce an apoptotic cascade causing retinal degeneration [Grimm et al., 
2000; Wenzel et al., 2005]. As a downstream signal of light-induced signaling, anti-apoptotic 
proteins, including erythropoietin (EPO) and subsequent Janus kinase 2 (Jak2) 
phosphorylations, are tightly linked to a specific temporal period after oxidative stress and 
in anticipation of daily light onset. This is consistent with physiological protection against 
daily light-induced, oxidative mediated retinal apoptosis [Noell et al., 1966; Chung et al, 
2009]. Continuous exposure to bright light (5000 lux) within 60 minutes induced apoptosis 
in retinal cells by activating caspase-3 signals. This suggests that endogenous 
neuroprotective proteins may not be sufficient in such intense oxidative stress conditions. 
Thus, we are seeking to define effective endogenous physiological neuroprotective 
strategies for anti-apoptosis from light-induced, oxygen-mediated damages that have 
clinical relevance.  
The expression levels of a scaffold subunit of PP2Aa and vimentin are significantly 
increased when mice are exposed under continuous light for 7 days compared to control in 
rd 1 degeneration model [Zhang et al., 2010]. When melatonin is administered to animals 
while they are exposed to continuous light, the levels of vimentin and PP2A return to a 
normal level. Vimentin is a PP2A target of direct dephosphorylation. Vimentin is present in 
all mesenchymal cells and often used as a differentiation marker. Like other intermediate 
filaments, vimentin acts to maintain cellular integrity; further, vimentin may play a role in 
adhesion, migration, and cellular survival in the RPE. We demonstrated that bright light up-
regulates pro-apoptotic signaling by cleavage of caspase-3 and Bcl-xL [Chung et al., 2009].  
Exposure to continuous light at intensities ordinarily encountered during daytime causes 
retinal degeneration. How constant light induces retinal degeneration remains unknown, 
although potential mechanisms have been proposed, including defects in rhodopsin 
regeneration, accumulation of free radicals, and a continuous low level of Ca2+ resulting 
from an excessively active phototransduction cascade.  
We examined the impact of constant light-exposed proteome changes in vivo. We exposed 
mice to either light (250-300 lux) for 12 hours followed by 12 hours of darkness or the same 
intensity of continuous light for seven days. Two proteins up-regulated by continuous light 
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were identified as PP2A and vimentin by mass spectrometry. We examined cytoskeletal 
proteins as potential substrates of PP2A. Cytoskeletal filament proteins were upregulated 
under constant light condition in vivo. Neurofilament, intermediate filament vimentin, 
tubulin, and actin increased in different levels under constant light exposure. The 
cytoskeletal target proteins were further analyzed by mass spectrometry to determine their 
modifications. Site-specific nitration and phosphorylations were found in PP2A and 
filament proteins.  
 
Protein Site Modification 
PP2Aa Y169 nitration 
Actin b cytoplasmic 1 T186 phosphorylation 
Tubulin b 2B Y50, Y51, T55 phosphorylation 
Tubulin b 5 Y159 nitration 
Tubulin b 5 S168, S172 phosphorylation 
Vimentin Y38, S325 ,S412, S420 phosphorylation 
Table 3. Modifications of PP2A and filament proteins under constant light in vivo 
Vimentin is a major component of intermediate filament that spread throughout the cell and 
serve as signal transducer conveying mechanical and molecular information from cell 
surface to nucleus and intracellular compartments. Neuronal cytoskeleton is a potential 
therapeutic target in neurodegenerative diseases. Vimentin phosphorylations were further 
analyzed by 2D electrophoresis with narrow range of pI for higher resolution. Vimentin 
phosphorylation decreased under constant light in vivo. Modifications of vimentin are 
essential reactions of filament dynamics. Changes of vimentin phosphorylation are directed 
to reorganization of the intermediate filament network and altered function of Müller cells.  
Hyperphosphorylation of vimentin can disassemble intermediate filament into soluble 
monomeric form. Müller cells are the major glial cells in the retina and play crucial roles in 
maintaining neuroretinal architecture and support neuronal survival. Our results suggest that 
vimentin and Müller cells might be critically involved in the process of light-induced damage 
in the retina. By reducing the light-induced post-translational modification of vimentin, PP2A 
may assist to maintain the proper filament network in Müller cells, which subsequently 
supports neuronal survival and architecture in the retina. To test changes of PP2A and 
cytoskeletal proteins in RPE in vitro, we examined ARPE-19 cells under stress condition. When 
RPE cells were under oxidative stress (100-250 M H2O2), a catalytic subunit PP2Ac was 
initially upregulated, then decreased in time and dose dependent manner.  
A decrease in cytoskeletal protein turnover leads to the accumulation of large aggregates of 
actin and tubulin, which triggers an increase in the levels of reactive oxygen species (ROS). 
Dynamic and differential changes in the cytoskeleton occur in apoptotic cellular processes. 
Thus, we ask how phosphorylation of vimentin regulates cytoskeletal dynamics and cell 
survival under stress conditions in RPE. We hypothesize that the modifications of PP2A and 
vimentin influence the cytoskeletal network through interplay with other cytoskeletal proteins. 
A stabilized vimentin may act as an antiapoptotic agent when cells are under stress.  
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Methylation and phosphorylation of PP2A catalytic c subunit are evolutionary conserved 
mechanisms that critically control the PP2A holoenzyme assembly and substrate specificity. 
However, interplay of PP2A nitration and phosphorylation that may control subunit 
binding has never been studied.  
Regulation of tyrosine nitration could be a potential intervention of early stage light-
induced ocular diseases. We postulate, on the basis of our data, that modifications of PP2A 
and vimentin influence the cytoskeletal network through interplay with other cytoskeletal 
proteins, including tubulin and actin. A positive correlation between the levels of PP2A and 
vimentin under light-induced stress suggests that cytoskeletal dynamics is regulated by 
dephosphorylation of vimentin as a PP2A substrate.  
To examine PP2A and cytoskeletal proteins under oxidative stress, we examined light-
induced cytoskeletal changes using ARPE-19 cells. ARPE-19 contains retinal G-protein 
receptors (RGR) and peropsin as light detecting chromophores. The assembly of the major 
cytoskeleton proteins, including vimentin, tubulin and actin, are highly interdependent. 
Thus, we investigated -tubulin and the interplay of vimentin dynamics with microtubules 
under light. Tubulin is a highly concentrated building block (10–20 µM) of microtubules. -
tubulin is aggregated as shown by particles (white arrow) under intense light (Figure 5). b-
tubulin is colocalized with mitochondria in dark, but changed localization under light 
condition. Confluent ARPE-19 cells were treated with either dark or 7000 lux white light for 
2 hr. Mitochondria was stained by 100 nM MitoTracker Orange. β-tubulin was visualized by 
Alexa 488 secondary antibody and the nucleus was stained by DAPI. To follow vimentin-
tubulin interaction changes in light, we analyzed tubulin polymerization rates and 
vimentin-tubulin colocalization. -tubulin is a major component of the microtubule and also 
an essential component of the cytoskeleton. They play a critical role in cell division and cell 
motility. Our results demonstrated that actin filament also aggregated in cytosol under 
intense light condition in RPE. In the dark, -actin is localized in cytosol, but in light -actin 
is aggregated outside of mitochondria. Light-induced modification of cytoskeletal proteins 
may imply a potential regulatory mechanism in apoptosis. Direct interaction between 
vimentin and actin has been observed [Esue et al., 2006]. The tail domain of vimentin 
intermediate filaments interacts directly with actin, which may regulate cytoskeletal 
crosstalk. Morphologic change and cytoskeletal reorganization of RPE cells were observed 
under oxidative stress in vitro.  
9. The visual cycle 
The steady-state of retinoid concentration and photosensitivity are controlled by the 
biosynthetic pathway leading to 11-cis-retinal regeneration, which is called the visual cycle. 
For continued vision, 11-cis-retinoid must be regenerated by a series of enzymes, including 
retinol dehydrogenases (RDHs), lecithin retinol acyltransferase (LRAT), and RPE65 [Saari 
2000; Rando 2001; Jahng et al 2002; Jahng et al., 2003a; Jahng 2003b; Bok et al., 2003; Xue et 
al., 2004; Xue et al., 2006] (Figure 1). 
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Figure 1. Biochemical reactions in the visual cycle and two palmitoylation transfer steps.  
RPE is susceptible to oxidative stress due to its high oxygen consumption, the generation of 
reactive oxygen species (ROS), the presence of a high percentage of unsaturated fatty acids, 
and exposure to light [Bok, 1993; Strauss, 2005]. RPE65, a peripheral membrane protein of 
RPE cells, is thought to be an all-trans-retinyl ester isomerohydrolase [Moiseyev et al, 2005; 
Jin et al, 2005; Redmond et al, 2005]. In conjunction with other proteins, it isomerizes all-
trans-retinyl ester and hydrolyzes it into 11-cis-retinol, the immediate precursor to 11-cis-
retinal Schiff base chromophore which is enzymatically regenerated in the RPE. RPE65 was 
originally identified as the putative RPE membrane receptor for the plasma retinol-binding 
protein, and later shown to be a retinoid binding protein with high affinity toward all-trans-
retinyl palmitate [Hooks et al, 1989; Bavik et al, 1991; Bavik et al, 1992; Bavik et al, 1993; 
Hamel et al, 1993a; Hamel et al, 1993b; Tsilou et al, 1997; Ma et al., 2001; Jahng et al., 2003a; 
Gollapalli et al, 2003; Mata et al, 2004; Xue et al, 2004]. It is homologous to beta-carotene 
monooxygenase [Kloer et al., 2005]. 
RPE contains anti-apoptotic and neuroprotective factors to support retina survival and 
maintenance. With aging, an imbalance occurs between ROS production and the capacity 
for detoxification resulting in the accumulation of ROS and the diminution of mitochondrial 
respiratory function. These ROS may contribute to the development of eye diseases such as 
cataract [Spector, 1995], uveitis [Satici et al, 2003; Bosch-Morell et al, 2002], glaucoma 
[Osborne et al, 1999; Babizhayev et al, 1989], retinopathy of prematurity [Dani et al, 2004; 
Head 1999], AMD [Beatty et al, 2000; Spraul 1996], and diabetic retinopathy [Kowluru et al, 
1994]. Thus, understanding the mechanism of elevated ROS during aerobic metabolism and 
the resulting oxidative stress is important to the treatment of eye diseases. Under sub-lethal 
conditions of oxidative stress, mitochondrial respiratory function is impaired by electron 
leakage [Yakes and Van Houten, 1997; Melov et al, 1999] leading to decreased ATP 
production. Moreover, elevated ROS induce mutations in mitochondrial DNA, oxidative 
damage to cellular macromolecules forming cross-linked aggregates, and accumulation of 
damaged proteins [Grune et al, 1997].  
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Several mutations in the RPE65 gene have been shown to be associated with retinal 
degenerations, including autosomal recessive childhood-onset severe retinal dystrophy, 
Leber’s congenital amaurosis (LCA), and retinitis pigmentosa [Gu et al., 1997; Chen et al., 
2006; Cottet et al., 2006; Hamel et al., 2001; Travis et al., 2007; Felius et al., 2002]. The RPE65 
L450M mutant is associated with the reduced concentration of A2E lipofuscin [Kim et al., 
2004]. RPE65 is essential for 11-cis-retinol biosynthesis in vivo and in vitro [Redmond et al., 
1998; Nicolaeva et al., 2009]. Studies using RPE65 knockout mice demonstrate the 
importance of RPE65 in 11-cis-retinal biosynthesis in vivo [Redmond et al, 1998]. The 
synthesis of 11-cis-retinal is eliminated in these mice, while all-trans-retinyl esters 
accumulate as oil droplets in RPE cells. The control elements that regulate the overall 
biosynthetic pathway to 11-cis-retinal under light and oxidative stress are not known. 
Furthermore, connection between the visual cycle and resulting redox imbalance is in 
question.  
In 1989, Rando proposed that RPE membranes might be the energy source for isomerization 
of all-trans-retinyl ester to 11-cis-retinol [Deigner et al., 1989]. In his hypothesis, the free 
energy of hydrolysis of the retinyl ester is coupled to the endothermic trans to cis 
isomerization. However, there are series of questions inlcuding; 1) C11 position is not 
nucleophilic and palmitate is not a good leaving group; 2) isomerization of the conjugated 
double bond of the retinoid cannot be explained in this mechanism. In 1999, Palczewsky 
proposed a carbocation intermediate mechanism [Stecher et al., 1999]. They suggested that 
the regeneration of 11-cis retinal might occur through a retinyl carbocation based on the 
observation of inhibition by positively charged retinoid as transition state analog. Both 
hypotheses do not explain the 11-cis-specific isomerization reaction of conjugated double 
bonds. Rather, singlet oxygen may bind to iron (Fe2+) in the active site of RPE65 and catalyze 
C11 specific isomerization through oxygen radical-mediated epoxide intermediate as shown 
in Figure 2.  
 
Figure 2. Putative Retinoid Isomerization Mechanism 
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al., 2009; Lee et al., 2010a]. Also, the level of RPE45 is present in cells exposed to high 
oxidative stress in vitro and in vivo [Lee et al., 2010a]. We further suggest that the RPE45 
fragment may be generated via ubiquitination involving interaction of specific proteases 
with RPE65. We also identified that retinaldehyde binding protein (CRALBP1) in the Müller 
cell showed a reversal of expression under constant light after melatonin treatment 
compared to constant light only condition (light vs. light+melatonin) [Zhang et al., 2010). 
Light-induced CRALBP1 may accelerate the retinal damage through higher rate of the 
visual cycle.  
Interestingly, C57BL/6 mice have a gene polymorphism (M450) associated with lower level 
of RPE65 expression and reduced light-damage sensitivity. We observed a higher threshold 
for RPE45 appearance when RPE cells were exposed to light and oxidative stress 
simultaneously compared to cells under oxidative stress alone, suggesting that the 
protective mechanism may exist to maintain RPE65 concentration under light-induced 
oxidative stress.  
We examined the appearance of RPE45 and RPE20 fragments in vitro with different amounts 
of H2O2 (100, 300, 500 and 1000 µM) in order to mimic different levels of oxidative stress on 
bovine RPE cells. As expected, RPE45 and RPE20 were produced in a dose-dependent 
manner after H2O2 treatment.  
To address the functional significance of RPE45, we tested the ability of the RPE45 fragment 
to bind biotinylated all-trans-retinyl chloroacetate (BRCA), an all-trans retinyl ester analog 
used to investigate the retinoid-binding roles of RPE proteins. In this experiment, RPE 
proteins from bovine RPE cells were incubated with BRCA 50 M/100 mg RPE proteins and 
separated by SDS-PAGE. BRCA-labeled proteins were visualized using an avidin-
peroxidase antibody and an anti-RPE65 peptide antibody. BRCA-labeled RPE65, RPE45 and 
LRAT were confirmed by electrospray tandem mass spectrometry and Western-blot 
analyses, demonstrating that RPE45 binds this all-trans-retinyl ester analog.     
A defect in RPE65 can trigger a remodeling of the retina that may disrupt photoreceptor 
homeostasis and induce apoptosis cascades leading to retinal degeneration [Shang and Taylor, 
2004]. Light influences the translocation of transducin, arrestin, and recoverin; tyrosinase-
mediated light adaptation, and the synthesis of retinoic acid and melatonin. Our studies 
indicate that oxidative stress and light exposure can influence the visual cycle. The dose-
dependent induction of RPE45, a fragment of RPE65 generated in response to H2O2 or light 
exposure by a specific caspase-mediated cleavage suggests that RPE45 is a potential signaling 
molecule of oxidative stress- and light-induced apoptosis [Chung et al., 2009; Lee et al., 2010a]. 
Proteolysis after stress is an important signal transduction pathway mediated by caspases, 
presenilin, and amyloid precursor protein, which can lead to neurodegenerative disorder or 
inflammation [Martinon and Tschopp 2004; Shi 2004; Haass and Strooper 1999]. We also 
observed up-regulation of NF-kB and amyloid beta in the RPE under oxidative stress. RPE65 is 
known as highly uveitogenic and antigenic protein implying involvement in pathogenic 
autoimmune diseases in the eye [Ham et al, 2002]. Changes in RPE65 expression are also seen 
in vivo during cycles of light and dark and may be mediated by light cues.  
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In nature, all biochemical reactions are dependent on the coupling of the free energy 
changes of phosphate- (ATP), thio- (CoA), and oxy- (membrane lipids) esters. For all-trans-
retinyl ester isomerization/hydrolysis biochemical reactions catalyzed by RPE65, palmitoyl 
transfer reaction should be coupled with retinyl ester isomerization and retinyl ester 
hydrolysis energetically and chemically. 
We suggest that RPE45 may result from degradation of RPE65 by ROS-induced proteases 
[Budihardjo et al., 1999; Santoro et al., 1998]. It is likely that RPE cells have a defense 
mechanism against oxidative stress and we therefore investigated the expression of anti-
apoptotic factors in oxidative stress. We found that anti-apoptotic Bcl-xL was increased 
under intense light [Chung et al., 2009]. The positive correlation between the expression of 
these anti-apoptotic factors and RPE65 under oxidative stress suggests that RPE65 may have 
a positive role in apoptotic signaling. Proteolysis after stress is an important signal 
transduction mediated by caspases, presenilin, and amyloid precursor protein, which can 
lead to neurological disorder or inflammation in the retina and brain [Martinon and 
Tschopp 2004, Shi 2004, Haass and Strooper 1999]. RPE65 is known as highly uveitogenic 
protein implying involvement in pathogenic autoimmune disease in the eye [Ham et al. 
2002]. Under oxidative stress, aged cells increase the number of mitochondria and induce 
anti-oxidant genes [Sitte et al, 2000; Lee et al, 2000]. Retinoid map in the retina and the RPE 
is shown in Figure 3. Potential target sites to regulate retinoid and A2E are shown in red 
bars.  
 
Figure 3. Retinoid Map in the Retina and RPE cells 
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10. Conclusion 
While the end point of apoptosis is well established, there is still a large gap between 
knowledge of early biochemical events and the end stage of age-related macular 
degeneration (AMD). Proteome changes under oxidative stress have been studied in regard 
to the pathogenesis of AMD [Yang et al 2006]. Understanding the molecular mechanism of 
proteomic signaling will provide a novel insight into apoptotic processes in AMD. It is 
expected that the knowledge will be equally applicable for understanding the lipid-
mediated cell death mechanism.  
Light-induced retinal degeneration in animal model occurs only when the visual cycle is 
functional. Regeneration of 11-cis-retinal as a chromophore of rhodopsin is depending on 
biochemical reactions of retinoid processing enzymes, including lecithin retinol 
acyltransferase and RPE65 [Xue et al., 2004; Xue et al., 2006; Jahng et al., 2003a; Jahng et al., 
2003b; Jahng et al., 2002; Bok et al., 2003]. Activity and expressions of these enzymes might 
be controlled by circadian regulators or daily light onset [Xue et al., 2004; Chung et al., 2009; 
Lee et al., 2010a]. A study of RPE65 knockout mice exhibited that light damage only occurs 
when the retina is supplied with 11-cis retinal [Wenzel et al., 2005]. Additional evidence in 
RPE65 L450M mice showing slow rhodopsin regeneration, halothane anesthesia as 
inhibition method of 11-cis-retinal regeneration, and 13-cis-retinoic acid as a putative RPE65 
inhibitor imply that continuous regeneration of 11-cis-retinal is one of the key steps to 
induce retina degeneration [Wenzel et al., 2005]. Our goal is to explicate the role of light and 
time under oxidative stress in the control of neuroprotective protein expressions in the 
retina and the RPE [Zimmermann et al., 2006]. Our questions include whether antiapoptotic 
factors, that include prohibitin, nitric oxide, vimentin, PP2A, and erythropoietin can protect 
retina and RPE cells against oxidative- or light-induced apoptotic neurodegeneration at 
specific time points.  
Our proteomic approaches to understand RPE cell death under stress conditions 
demonstrate that: 1) crystallins are upregulated and hyperphosphorylated. 2) 
neuroprotective erythropoietin and subsequent JAK2 phosphorylations are tightly linked to 
a specific time after oxidative stress and in anticipation of daily light onset. 3) early signaling 
molecules, including mitochondrial prohibitin, changes their expression, subcellular 
localization, phosphorylation, and lipid interaction under oxidative stress. 4) relative lipid 
compositions, including phosphatidylcholine and cholesterol, are altered under oxidative 
stress. 5) oxidative stress leads to cytoskeletal reorganization through site-specific vimentin 
phosphorylations that regulate intermediate filaments, resulting in nonfilamentous particles.  
AMD is characterized in its early stages by the presence of extracellular deposits, known as 
drusen, that accumulates between the basal surface of the RPE and Bruch’s membrane. 
During the past decade, compelling evidence has emerged implicating the immune system 
and the complement system in particular in drusen biogenesis and AMD. A number of the 
proteins detected in drusen are either complement components or related molecules. 
Despite these significant advances, the identity of the molecules responsible for triggering 
activation of the complement cascade, as well as the downstream molecular interactions that 
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promote AMD pathology, remain elusive. Our proteomics studies will provide new insight 
into the underlying mechanisms involved in the development and progression of AMD and 
further elucidate the relationship between various risk facotors, including oxidative stress 
and complemnt activation. Such information are critical for the development of more 
effective therapeutic strategies for the treatment of retinal degeneration that includes AMD. 
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